Is intensive management of blood pressure to prevent visual loss in persons with type 2 diabetes indicated?
Klein
Ronald
R
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D014786:Vision Disorders / Q000209:etiology / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors